[1]
I. Kang, “Improved growth performance by type 2 porcine reproductive and respiratory syndrome virus (PRRSV)-based modified live vaccine in a herd with concurrent circulation of type 1 and type 2 PRRSV”, TJVM, vol. 47, no. 1, pp. 109–115, Apr. 2017.